ESMO24 - Precision Oncology

Explore the latest advances and innovative treatments in precision oncology.

Our Experts

For this coverage, we have selected these experts who will share their knowledge and experiences, providing a valuable and enriching perspective for all attendees.

Dr. Ben Westphalen

Department of Internal Medicine III - Ludwig-Maximilians University of Munich | LMU, Germany.

David S. Hong MD

Department of Investigative Therapeutic Cancer, MD Anderson Cancer Center, Texas, USA.

Radu Vidra MD, PhD

Regional Institute of Gastroenterology and Hepatology Prof. Dr. Octavian Fodor, Cluj-Napoca, Romania.

20 sept 2024

The importance of molecular tumour profiling

What is the best resource for physicians to understand and apply precision medicine in oncology? How do molecular profiles lead to more accurate diagnoses? The experts address these questions and discuss other important aspects of the topic during the conversation.

20 sept 2024

Implementation of biomarker testing in routine clinical practice

On the path to precision oncology, biomarker testing plays a crucial role. From biopsy logistics to mutation interpretation, this approach is transforming how cancer is treated. Additionally, the concept of teamwork through boards focused on evaluating cancer patients is gaining importance. Learn more about the challenges oncologists face and the solutions driving the implementation of precision medicine in daily practice.

20 sept 2024

Take Home Messages

Discover the steps that specialists recommend to integrate precision oncology into the everyday routine of oncologists.